175 related articles for article (PubMed ID: 30991288)
1. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Miramontes-González JP; Usategui-Martín R; Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Jiménez FF; Martín-Vallejo J; Rodríguez Gude AE; Jiménez DL; Padro T; González-Sarmiento R; Mata P
Atherosclerosis; 2019 Jun; 285():17-22. PubMed ID: 30991288
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
Escate R; Padró T; Pérez de Isla L; Fuentes F; Alonso R; Mata P; Badimon L
Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437
[TBL] [Abstract][Full Text] [Related]
3. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia.
Paquette M; Dufour R; Baass A
J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573
[TBL] [Abstract][Full Text] [Related]
4. Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.
Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Miramontes JP; Fuentes F; Gómez de Diego JJ; González-Estrada A; Mata N; Saltijeral A; Barreiro M; Tomás M; de Andrés R; Argüeso R; Serrano Gotarredona MP; Navarro Herrero S; Perea Palazón RJ; de Caralt TM; Suárez de Centi LA; Zhilina S; Espejo Pérez S; Padró T; Mata P;
J Clin Lipidol; 2018; 12(4):948-957. PubMed ID: 29753733
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
[TBL] [Abstract][Full Text] [Related]
6. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.
Gallo A; Pérez de Isla L; Charrière S; Vimont A; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Moulin P; Bruckert E; Mata P; Béliard S;
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2414-2424. PubMed ID: 34274263
[TBL] [Abstract][Full Text] [Related]
7. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
8. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD
Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609
[TBL] [Abstract][Full Text] [Related]
9. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
[TBL] [Abstract][Full Text] [Related]
10. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
Miname MH; Bittencourt MS; Nasir K; Santos RD
Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases.
Wang L; Ge H; Peng L; Wang B
Clin Cardiol; 2019 Oct; 42(10):860-865. PubMed ID: 31339592
[TBL] [Abstract][Full Text] [Related]
12. Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia.
ten Kate GL; ten Kate GJ; van den Oord SC; Dedic A; Dharampal AS; Nieman K; de Feyter PJ; Sijbrands EJ; van der Steen AF; Schinkel AF
Am J Cardiol; 2013 May; 111(9):1305-10. PubMed ID: 23411100
[TBL] [Abstract][Full Text] [Related]
13. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
[TBL] [Abstract][Full Text] [Related]
14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
Mata P; Alonso R; Pérez de Isla L
Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
[TBL] [Abstract][Full Text] [Related]
16. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
Paquette M; Dufour R; Baass A
Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants and Haplotypes in
Pérez-Hernández N; Posadas-Sánchez R; Vargas-Alarcón G; Cazarín-Santos BG; Miranda-Duarte A; Rodríguez-Pérez JM
DNA Cell Biol; 2020 Nov; 39(11):2085-2094. PubMed ID: 32955941
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism rs2073618 of the osteoprotegerin gene as a potential marker of subclinical carotid atherosclerosis in Caucasians with type 2 diabetes mellitus.
Pleskovič A; Ramuš SM; Pražnikar ZJ; Šantl Letonja M; Cokan Vujkovac A; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
Vasa; 2017 Aug; 46(5):355-362. PubMed ID: 28593808
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
20. Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
Mangili LC; Mangili OC; Bittencourt MS; Miname MH; Harada PH; Lima LM; Rochitte CE; Santos RD
Atherosclerosis; 2016 Nov; 254():73-77. PubMed ID: 27705756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
